IFN-alpha/beta R1

IFN-alpha/beta R1

IFN-alpha/beta R1 분자 정보

Molecule Name
Interferon-alpha/beta receptor alpha chain
분자 별명
IFNAR1,IFNAR,CRF2-1,IFN-R-1,IFNAR-1
Drug Development Progress
임상 약물 수0
시판 약물 수5
최고 연구 개발 단계Approved
표적 별명
IFNBR,IFN-Alpha-REC,Beta-Type Antiviral Protein,IFNAR,Cytokine Receptor Class-II Member 1,Interferon Receptor 1,IFNAR1,Interferon Alpha/Beta Receptor 1,Interferon Alpha And Beta Receptor Subunit 1,Type I Interferon Receptor 1,Interferon (Alpha, Beta And Omega) Receptor 1,Alpha-Type Antiviral Protein,IFN-Alpha/Beta Receptor 1,AVP,Interferon-Beta Receptor 1,IFRC,IFN-R-1,CRF2-1,Cytokine Receptor Family 2 Member 1,Interferon-Alpha/Beta Receptor Alpha Chain
분자 배경
Interferon alpha/beta receptor 1 ( IFNAR1) is also known as Cytokine receptor class-II member 1, Cytokine receptor family 2 member 1 (CRF2-1), Type I interferon receptor 1, IFNAR, which belongs to the type II cytokine receptor family. IFNAR1 /IFNAR contains four fibronectin type-III domains. IFNAR1 associates with IFNAR2 to form the type I interferon receptor. IFNAR1 is receptor for interferons alpha and beta. IFNAR1 can transduce IFNB signals without the help of IFNAR2, and not activating the Jak-STAT pathway.

IFN-alpha/beta R1 제품 목록

Species
  • Human(7)
  • Cynomolgus(1)
  • Mouse(1)
Tag
  • His Tag(5)
  • His Tag & Avi Tag(3)
  • Fc Tag(1)
Host
  • HEK293(9)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(3)
Grade
  • RUO(9)
Low Endotoxin
  • Yes(2)
  • No(7)
You Have Viewed 1-9 Of 9 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Interferon beta (Toray/Daiichi Sankyo)DL-8234ApprovedToray Industries IncFeronJapanMedulloblastoma; Melanoma; Hepatitis C; Astrocytoma; Glioblastoma; Hepatitis Bnull1985-04-01
Astrocytoma; Glioblastoma; Hepatitis B; Hepatitis C; Medulloblastoma; Melanoma
상세
Recombinant human interferon alfa-2b (Harbin Pharmaceutical Group Bioengineering)ApprovedHarbin Pharmaceutical Group Holding Co Ltd里亚美, 利分能Mainland ChinaHepatitis, Viral, Human; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Condylomata Acuminata; Varicella Zoster Virus InfectionHarbin Pharmaceutical Group Pharmaceutical Co Ltd1996-01-01
Condylomata Acuminata; Hepatitis, Viral, Human; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Varicella Zoster Virus Infection
상세
Recombinant human interferon α2b biosimilar (Harbin High-Tech White Swan Pharmaceutical)ApprovedHarbin High-Tech Group Baitian'Er Pharmaceutical Co LtdFu Li Sheng
Condylomata Acuminata; Hepatitis; Herpes Zoster; Leukemia, Hairy Cell; Leukemia, Myeloid, Chronic-Phase; Lymphoma, Non-Hodgkin; Multiple Myeloma
상세
AnifrolumabMEDI-546; MDX-1333ApprovedMedarex Inc, Medimmune LlcSAPHNELOUnited StatesLupus Erythematosus, SystemicAstrazeneca Ab2021-07-30
Atherosclerosis; Autoimmune Diseases; Cardiovascular Diseases; Dermatomyositis; Hidradenitis; Hidradenitis Suppurativa; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Nephritis; Myositis; Polymyositis; Scleroderma, Systemic; Sjogren's Syndrome; Vitiligo
상세
Recombinant human interferon α2b biosimilar (Zhejiang Hansheng)ApprovedZhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma莱福隆Mainland ChinaVirus Diseases; NeoplasmsZhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma1999-01-01
Neoplasms; Virus Diseases
상세
Customer Reviews